AT359191B - Verfahren zur herstellung von neuen derivaten des daunorubicins - Google Patents

Verfahren zur herstellung von neuen derivaten des daunorubicins

Info

Publication number
AT359191B
AT359191B AT500478A AT500478A AT359191B AT 359191 B AT359191 B AT 359191B AT 500478 A AT500478 A AT 500478A AT 500478 A AT500478 A AT 500478A AT 359191 B AT359191 B AT 359191B
Authority
AT
Austria
Prior art keywords
daunorubicin
producing new
new derivatives
derivatives
producing
Prior art date
Application number
AT500478A
Other languages
English (en)
Other versions
ATA500478A (de
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of ATA500478A publication Critical patent/ATA500478A/de
Application granted granted Critical
Publication of AT359191B publication Critical patent/AT359191B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT500478A 1977-07-11 1978-07-11 Verfahren zur herstellung von neuen derivaten des daunorubicins AT359191B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7721272A FR2397425A1 (fr) 1977-07-11 1977-07-11 Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent

Publications (2)

Publication Number Publication Date
ATA500478A ATA500478A (de) 1980-03-15
AT359191B true AT359191B (de) 1980-10-27

Family

ID=9193210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT500478A AT359191B (de) 1977-07-11 1978-07-11 Verfahren zur herstellung von neuen derivaten des daunorubicins

Country Status (11)

Country Link
US (1) US4185111A (de)
JP (1) JPS5419959A (de)
AT (1) AT359191B (de)
AU (1) AU3791178A (de)
BE (1) BE868888A (de)
DE (1) DE2830488A1 (de)
FR (1) FR2397425A1 (de)
GB (1) GB2001987A (de)
IT (1) IT1096695B (de)
NL (1) NL7807215A (de)
ZA (1) ZA783939B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
US5212291A (en) * 1986-10-23 1993-05-18 American Cyanamid Company Anthracycline derivatives as solubilized pro-drugs
US5716990A (en) * 1987-03-09 1998-02-10 Cancer Research Campaign Technology Limited Drug delivery systems
US4975278A (en) * 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
NZ225599A (en) 1987-08-04 1991-09-25 Bristol Myers Co Antibody-enzyme conjugates and combinations with prodrugs for the treatment of tumour cells
US4904768A (en) * 1987-08-04 1990-02-27 Bristol-Myers Company Epipodophyllotoxin glucoside 4'-phosphate derivatives
US5632990A (en) * 1988-04-22 1997-05-27 Cancer Research Campaign Tech. Ltd. Treatment for tumors comprising conjugated antibody A5B7 and a prodrug
US4874779A (en) * 1988-06-29 1989-10-17 Bristol-Myers Company Mitomycin phosphate derivatives
CN107849070B (zh) * 2015-08-10 2021-08-06 斯泰拉化工公司 磷酸二酯盐、其制造方法、蓄电元件的非水电解液及蓄电元件

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012448A (en) * 1976-01-15 1977-03-15 Stanford Research Institute Synthesis of adriamycin and 7,9-epiadriamycin

Also Published As

Publication number Publication date
NL7807215A (nl) 1979-01-15
ATA500478A (de) 1980-03-15
US4185111A (en) 1980-01-22
AU3791178A (en) 1980-01-17
ZA783939B (en) 1979-07-25
JPS5419959A (en) 1979-02-15
IT7825559A0 (it) 1978-07-11
FR2397425B1 (de) 1980-02-01
FR2397425A1 (fr) 1979-02-09
DE2830488A1 (de) 1979-01-25
BE868888A (fr) 1979-01-10
GB2001987A (en) 1979-02-14
IT1096695B (it) 1985-08-26

Similar Documents

Publication Publication Date Title
AT367425B (de) Verfahren zur herstellung von neuen cephemderivaten
AT367426B (de) Verfahren zur herstellung von neuen cephemderivaten
AT362065B (de) Verfahren zur herstellung von neuen pleuromutilinglycosidderivaten
AT363182B (de) Verfahren zur herstellung von neuen cephemderivaten
AT357673B (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
LU78919A1 (de) Verfahren zur herstellung von neuen aminoalkoxyphenyl-derivaten
AT357274B (de) Verfahren zur herstellung von neuen derivaten des 20,21-dinoreburnamenins
AT359191B (de) Verfahren zur herstellung von neuen derivaten des daunorubicins
AT367431B (de) Verfahren zur herstellung von neuen sisomycin-derivaten
AT365591B (de) Verfahren zur herstellung von neuen indolderivaten
AT352281B (de) Verfahren zur herstellung von neuen disaccharidderivaten von anthracyclinen
ATA472577A (de) Verfahren zur herstellung von neuen 1-acyl-4- -hydroxy-imidazol-5-carboxamid-derivaten
AT362368B (de) Verfahren zur herstellung von neuen oxazolidin- 2-on-derivaten
AT362501B (de) Verfahren zur herstellung von neuen acyl- derivaten
AT358202B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
AT371109B (de) Verfahren zur herstellung von neuen benzolsulfonamidderivaten
AT365203B (de) Verfahren zur herstellung von neuen 9-fluorprednisolon-derivaten
AT371119B (de) Verfahren zur herstellung von neuen sulfoximid-derivaten
AT359192B (de) Verfahren zur herstellung von neuen acyl- derivaten des antibiotikums bm123gamma
AT363473B (de) Verfahren zur herstellung von neuen 4-hydroxy-thiazolidin-2-thion-derivaten
AT365610B (de) Verfahren zur herstellung von neuen 19-nor-10cyano-peruvosid-derivaten
ATA86679A (de) Verfahren zur herstellung von neuen cis-4a-phenyl-isochinolinderivaten
ATA532778A (de) Verfahren zur herstellung von neuen 19-norpregnahexaenderivaten
AT361920B (de) Verfahren zur herstellung von neuen benzo- pyranoxanthenderivaten
ATA893878A (de) Verfahren zur herstellung von neuen 9-hydroxyaethoxymethylguaninderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee